Alzheimer’s Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Pages: 1715 Published: April 01, 2022 Report Code: GMDGDHC22106IDB

Alzheimer’s disease is a progressive, degenerative condition causing damage to memory and behavior due to the attack on the neurons. Predisposing factors include age, heredity, cardiovascular diseases or diabetes, and environmental factors. Symptoms include depression, anxiety, social withdrawal, irritability, and aggressiveness.

The Alzheimer’s Disease Drugs in Development market research report provides an overview of the Alzheimer’s Disease pipeline landscape. The report provides comprehensive information on the therapeutics under development for Alzheimer’s Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Alzheimer’s Disease and features dormant and discontinued projects.

Alzheimer’s Disease Pipeline Drugs Market Targets

The targets of the Alzheimer’s disease pipeline drugs market are Amyloid Beta A4 Protein, Microtubule Associated Protein Tau, Acetylcholinesterase, Glutamate Ionotropic Receptor NMDA Type Subunit, Apolipoprotein E, Muscarinic Acetylcholine Receptor M1, Gamma Secretase, Alpha Synuclein, Cholinesterase, and Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A.

Alzheimer’s Disease pipeline drugs market, by targets

Alzheimer’s Disease pipeline drugs market, by targets

For more target insights, download a free report sample

Mechanisms of Action of Alzheimer’s Disease Pipeline Drugs Market

The mechanisms of action of the Alzheimer’s disease pipeline drugs market are Amyloid Beta A4 Protein Inhibitor, Microtubule Associated Protein Tau Inhibitor, Acetylcholinesterase Inhibitor, Glutamate Ionotropic Receptor NMDA Type Subunit Antagonist, Muscarinic Acetylcholine Receptor M1 Agonist, Apolipoprotein E Inhibitor, Alpha Synuclein Inhibitor, Cholinesterase Inhibitor, Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Inhibitor, and Muscarinic Acetylcholine Receptor M4 Agonist.

Alzheimer’s Disease pipeline drugs market, by mechanisms of action

Alzheimer’s Disease pipeline drugs market, by mechanisms of action

For more mechanisms of action insights, download a free report sample

Routes of Administration in Alzheimer’s Disease Pipeline Drugs Market

The routes of administration in the Alzheimer’s disease pipeline drugs market are oral, intravenous, subcutaneous, nasal, parenteral, transdermal, intrathecal, inhalational, intramuscular, and topical.

Alzheimer’s Disease pipeline drugs market, by routes of administration

Alzheimer’s Disease pipeline drugs market, by routes of administration

For more routes of administration insights, download a free report sample

Molecule Types in Alzheimer’s Disease Pipeline Drugs Market

The molecule types in the Alzheimer’s disease pipeline drugs market are small molecule, monoclonal antibody, synthetic peptide, gene therapy, peptide, cell therapy, biologic, antibody, recombinant protein, and antisense oligonucleotide.

Alzheimer’s Disease pipeline drugs market, by molecule types

Alzheimer’s Disease pipeline drugs market, by molecule types

For more molecule type insights, download a free report sample

Key Alzheimer’s Disease Pipeline Drugs Market Companies

Some of the key companies in the Alzheimer’s disease pipeline drugs market are Biogen Inc, Anven AlzDx Inc, Eisai Co Ltd, F. Hoffmann-La Roche Ltd, Merck & Co Inc, Amyloid Solution Inc, Eli Lilly and Co, Alector Inc, AlzeCure Pharma AB, and AmyriAD Therapeutics BV.

Alzheimer’s Disease pipeline drugs market, by key companies

Alzheimer’s Disease pipeline drugs market, by key companies

To know more about key companies, download a free report sample

Market report overview

Targets Amyloid Beta A4 Protein, Microtubule Associated Protein Tau, Acetylcholinesterase, Glutamate Ionotropic Receptor NMDA Type Subunit, Apolipoprotein E, Muscarinic Acetylcholine Receptor M1, Gamma Secretase, Alpha Synuclein, Cholinesterase, and Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A
Mechanisms of Action Amyloid Beta A4 Protein Inhibitor, Microtubule Associated Protein Tau Inhibitor, Acetylcholinesterase Inhibitor, Glutamate Ionotropic Receptor NMDA Type Subunit Antagonist, Muscarinic Acetylcholine Receptor M1 Agonist, Apolipoprotein E Inhibitor, Alpha Synuclein Inhibitor, Cholinesterase Inhibitor, Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Inhibitor, and Muscarinic Acetylcholine Receptor M4 Agonist
Routes of Administration Oral, Intravenous, Subcutaneous, Nasal, Parenteral, Transdermal, Intrathecal, Inhalational, Intramuscular, and Topical
Molecule Types Small Molecule, Monoclonal Antibody, Synthetic Peptide, Gene Therapy, Peptide, Cell Therapy, Biologic, Antibody, Recombinant Protein, And Antisense Oligonucleotide
Key Companies Biogen Inc, Anven AlzDx Inc, Eisai Co Ltd, F. Hoffmann-La Roche Ltd, Merck & Co Inc, Amyloid Solution Inc, Eli Lilly and Co, Alector Inc, AlzeCure Pharma AB, and AmyriAD Therapeutics BV

Scope 

This report provides:

  • A snapshot of the global therapeutic landscape of Alzheimer’s Disease (Central Nervous System).
  • Reviews of pipeline therapeutics for Alzheimer’s Disease (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • Pipeline products based on several stages of development ranging from pre-registration to discovery and undisclosed stages.
  • Descriptive drug profiles for the pipeline products which include product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities.
  • Reviews of key companies involved in Alzheimer’s Disease (Central Nervous System) therapeutics and enlists all their major and minor projects.
  • Evaluation of Alzheimer’s Disease (Central Nervous System) targeted therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA), and molecule type.
  • All the dormant and discontinued pipeline projects.
  • Reviews of the latest news and deals related to pipeline therapeutics for Alzheimer’s Disease (Central Nervous System).

Reasons to Buy

  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Alzheimer’s Disease (Central Nervous System).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Alzheimer’s Disease (Central Nervous System) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Key Players

1st Bio Therapeutics Inc
2A Pharma AB
4B Technologies (Suzhou) Co Ltd
4P-Pharma SAS
AB Science SA
Abaxy Sprl
AbbVie Inc
Abrexa Pharmaceuticals Inc
Abyssinia Biologics LLC
AC Immune SA
Acadia Pharmaceuticals Inc
Accuitis Pharmaceuticals Inc
Acelot Inc
Actinogen Medical Ltd
Acumen Pharmaceuticals Inc
Addex Therapeutics Ltd
ADEL Inc
Adocia SAS
ADRx Inc
Aerobyx LLC
Aeton Therapeutics Inc
AevisBio Inc
AfaSci Inc
AIBIOS Co Ltd
Ailon Co Ltd
Akome Biotech Ltd
Alchemab Therapeutics Ltd
Alector Inc
Alfasigma SpA
Alkahest Inc
Alkermes Plc
Allyx Therapeutics Inc
Alnylam Pharmaceuticals Inc
Alopexx Inc
AlphaCognition Inc
Alsonex Pty Ltd
ALSP Inc
AltPep Corp
Alzamend Neuro Inc
AlzeCure Pharma AB
Alzheon Inc
Alzhyme Pty Ltd
Alzinova AB
AlzProtect SAS
Amyloid Solution Inc
Amylon LLC
Amylyx Pharmaceuticals Inc
AmyriAD Therapeutics BV
Anavex Life Sciences Corp
Anhorn Medicines Co Ltd
Anima Biotech Inc
Ankar Pharma SL
ANLBio Co Ltd
Annovis Bio Inc
Antoxerene Inc
Anven AlzDx Inc
Aphios Corp
Apollo Therapeutics LLC
Applied Research using OMIC Sciences SL
Aprinoia Therapeutics Inc
AptaBio Therapeutics Inc
Aquinnah Pharmaceuticals Inc
Araclon Biotech SL
Archer Pharmaceuticals Inc
AriBio
ArmaGen Inc
ARMGO Pharma Inc
Artery Therapeutics Inc
Arvinas Inc
Asceneuron SA
Asdera LLC
Ashvattha Therapeutics LLC
Asklepios BioPharmaceutical Inc
Astellas Pharma Inc
AstraZeneca Plc
Astrocyte Pharmaceuticals Inc
Astrogen Ltd
AstronauTx Ltd
Atalanta Therapeutics Inc
Athira Pharma Inc
ATP Biopharm
Atux Iskay Group LLC
Augustus BioTarget Inc
Auransa Inc
Aurin Biotech Inc
Autifony Therapeutics Ltd
Autophagy Neurotherapeutics Inc
Autotac Bio Inc
Avanti Biosciences Inc
Avidin Biotechnology Ltd
Avineuro Pharmaceuticals Inc
Axoltis Pharma SAS
Axon Neuroscience SE
Axxam SpA
AZTherapies Inc
Beijing Joekai Biotechnology LLC
Berg LLC
BeyondBio Inc
Bio-Pharm Solutions Co Ltd
BioArctic AB
Biogen Inc
Biohaven Pharmaceutical Holding Company Ltd
Biom Therapeutics LLC
Biorchestra Co Ltd
Biosplice Therapeutics Inc
BioVie Inc
BioXcel Therapeutics Inc
Bisichem Co Ltd
Boehringer Ingelheim International GmbH
Bolden Therapeutics Inc
Bolder Biotechnology Inc
Boryung Pharmaceutical Co Ltd
Brain Innovation Co Ltd
BrainStorm Cell Therapeutics Inc
Brainvectis SAS
Bright Minds Biosciences Inc
Buto Corp
C4 Therapeutics Inc
C4X Discovery Holdings Plc
Cantabio Pharmaceuticals Inc
Caren Pharmaceuticals Inc
Carna Biosciences Inc
CaSRevolution SRL
Cassava Sciences Inc
CavoGene LifeSciences
CellCure
CellTex Therapeutics Corp
Cenna Biosciences Inc
Cennerv Pharma (S) Pte Ltd
Center Laboratories Inc
CerebraMed
Cerecin Pte Ltd
Cerevance Inc
Cesa Alliance SA
CHA Biotech Co Ltd
Changchun Huayang High-Tech Co Ltd
Chaperone Therapeutics Inc
Chengdu Jinrui Foundation Biotechnology Co Ltd
Chengdu Kanghong Pharmaceuticals Group Co Ltd
Chimerna Therapeutics Inc
Chong Kun Dang Pharmaceutical Corp
Circadian Therapeutics
Circumvent Pharmaceuticals Inc
Clayton Biotechnologies Inc
Clene Inc
Clevexel Pharma SA
CMG Pharmaceutical Co Ltd
Cogentis Therapeutics Inc
Cognition Therapeutics Inc
Cognosci Inc
CohBar Inc
Collaborations Pharmaceuticals Inc
Collaborative Medicinal Development LLC
CoPlex Therapeutics LLC
Corium Inc
Cortexyme Inc
Cortice Biosciences Inc
Covalent Bioscience Inc
Coya Therapeutics Inc
Creative Bio-Peptides Inc
Crossbeta Biosciences BV
CuraSen Therapeutics Inc
Cure Network Dolby Acceleration Partners LLC
CuroNZ Ltd
Cyclerion Therapeutics Inc
Cyclica Inc
Cyclo Therapeutics Inc
CycloLab Cyclodextrin Research and Development Laboratory Ltd
Cytonus Therapeutics Inc
Dadang & BIO Co Ltd
Daewoong Pharmaceutical Co Ltd
DanDi Bioscience Inc
DanPET AB
DegenRx BV
Denali Therapeutics Inc
Denovo Biopharma LLC
Diffusion Pharmaceuticals Inc
Dong Wha Pharma Co Ltd
Dong-A ST Co Ltd
DongKoo Bio & Pharma Co Ltd
Dongkook Pharmaceutical Co Ltd
E-scape Bio Inc
Eagle Pharmaceuticals Inc
EastGate Pharmaceuticals Inc
Eikonizo Therapeutics Inc
EIP Pharma LLC
Eisai Co Ltd
Eleusis Ltd
Eli Lilly and Co
Elixirgen Therapeutics Inc
Elixiron Immunotherapeutics Inc
Emerald Organic Products Inc
EmphyCorp Inc
Empriver LLC
Endece LLC
Enterin Inc
Entrada Therapeutics Inc
Epigen Biosciences Inc
Epitracker Inc
Epsilon Molecular Engineering Inc
EuMentis Therapeutics Inc
Everfront Biotech Inc
Evero Health Ltd
Expesicor Inc
Exscientia Plc
F. Hoffmann-La Roche Ltd
Foresee Pharmaceuticals Co Ltd
Forest Hills Partners Hong Kong Ltd
Fortuna Fix Inc
Fox Chase Chemical Diversity Center Inc
FUJIFILM Toyama Chemical Co Ltd
G2GBIO Inc
GABA Therapeutics Inc
Gabaeron Inc
Gabather AB
Galimedix Therapeutics Ltd
GAOMA Therapeutics
GemVax & KAEL Co Ltd
Gene Therapy Research Institution Co Ltd
GeneLeap Biotech
Genentech USA Inc
Genervon Biopharmaceuticals LLC
GeneScience Pharmaceuticals Co Ltd
Genetic Intelligence Inc
Genuv Inc
Gismo Therapeutics Inc
GliaCure Inc
GliaPharm SA
Glycadia Inc
GNT Pharma Co Ltd
Golden Biotechnology Corp
Good T Cells Inc
GraySpace Therapeutics Inc
Grespo AB
Grifols SA
Guangzhou Dazhou Biomedical Technology Co Ltd
Guangzhou-Sheng Jian Chi Pharmaceutical Co Ltd
H. Lundbeck AS
Halia Therapeutics Inc
HEC Pharma Co Ltd
Herophilus
Holy Stone Healthcare Co Ltd
Hopstem Biotechnology LLC
Hoth Therapeutics Inc
Hyundai Pharma Co Ltd
ICB International Inc
Ildong Pharmaceutical Co Ltd
Imago Pharmaceuticals Inc
Immune System Key Ltd
Immuneering Corp
Immungenetics AG
ImmunoBrain Checkpoint Inc
ImmunoChem Therapeutics LLC
Immunwork Inc
Imnewrun Bioscience Co Ltd
Inmune Bio Inc
InnoBioscience LLC
Innosense LLC
Innovimmune Biotherapeutics Inc
Instituto Biomar SA
IntelGenx Corp
Interprotein Corp
Intra-Cellular Therapies Inc
IntraBio Ltd
INVENT Pharmaceuticals Inc
Invisio Ltd
Io Therapeutics Inc
Ionis Pharmaceuticals Inc
ISU ABXIS Co Ltd
Jace Biomedical Inc
Jiangsu Hengrui Medicine Co Ltd
Jiangsu Kangyuan Pharmaceutical Co Ltd
Jiangsu Kanion Pharmaceutical Co Ltd
Johnson & Johnson
Jupiter Neurosciences Inc
Kalgene Pharmaceuticals Inc
Karuna Therapeutics Inc
KeifeRx LLC
Keystone Bio Inc
Kine Sciences
KinoPharma Inc
Klogene Therapeutics Inc
Kogenix Therapeutics Inc
Korea Pharma Co Ltd
Kwang Dong Pharmaceutical Co Ltd
Kyowa Kirin Co Ltd
Landos Biopharma Inc
Lauren Sciences LLC
Lead Discovery Center GmbH
Lennham Pharmaceuticals Inc
LEXEO Therapeutics LLC
Libella Gene Therapeutics
Light Chain Bioscience
Longeveron Inc
LSL Neurosciences LLC
Luye Pharma Group Ltd
Lyndra Therapeutics Inc.
Magnolia Neurosciences Corp
ManRos Therapeutics
MapLight therapeutics Inc
Marvel Biotechnology Inc
MaxiVAX SA
MD Healthcare Inc
MDimune Inc
MedBiome Inc
Medesis Pharma SA
Medifron DBT Co Ltd
medilabo RFP Inc
MEDRx Co Ltd
MegaNano BioTech Inc
MEI Pharma Inc
Mercia Pharma Inc
Merck & Co Inc
MetiMedi Pharmaceuticals Co Ltd
MetrioPharm AG
MetVital Inc
MGC Pharmaceuticals Ltd
Mindset Pharma Inc
Mission Therapeutics Ltd
Mitoconix Bio Ltd
Montisera Ltd
MYND Life Sciences Inc
NAL Pharmaceuticals Ltd
Nanomerics Ltd
NatureWise Biotech & Medicals Corp
Neonc Technologies Inc
NeoNeuro SAS
NeoProgen Inc
NervGen Pharma Corp
NeuExcell Therapeutics Inc
Neuracle Genetics Inc
Neuracle Science Co Ltd
Neuraly Inc
Neuramedy Co Ltd
Neurano Bioscience
Neurim Pharmaceuticals Ltd
Neurimmune Holding AG
Neuro Bio Ltd
Neuro-Sys SAS
NeuroActiva Inc
Neurocrine Biosciences Inc
Neurodegeneration Therapeutics Inc
Neurodon LLC
NeuroGeneration Inc
NeuroGenesis Ltd
NeuroGenetic Pharmaceuticals Inc
Neurokine Therapeutics
NeuroLucent Inc
Neuromagen Pharma Ltd
NeuroNascent Inc
NeurOp Inc
Neuropore Therapies Inc
NeuroScientific Biopharmaceuticals Ltd
NeuroSense Therapeutics Ltd
NeuroSolis Inc
NeuroTau Inc
Neurotez Inc
NeuroTherpia Inc
NeuTherapeutics Inc
Neuvivo Inc
New World Laboratories Inc
NewAmsterdam Pharma BV
Nexel Co Ltd
Nippon Chemiphar Co Ltd
NKGen Biotech Inc
NoNO Inc
Novartis AG
NovMetaPharma Co Ltd
Novoron Bioscience Inc
Nymox Pharmaceutical Corp
Olatec Therapeutics LLC
Oleolive LLC
Oligomerix inc
OncoSynergy Inc
Ono Pharmaceutical Co Ltd
Orpheris Inc
Orphi Therapeutics Inc
Oryzon Genomics SA
OTR3 SAS
Overseas Pharmaceuticals Ltd
Oxstem Ltd
P2D Inc
Palisade Bio, Inc
Panorama Researchama Research
Paramag Biosciences
Park of Active Molecules
Paros Bio Inc
Partner Therapeutics Inc
Passage Bio Inc
Peptron Inc
Perha Pharmaceuticals SAS
Peter Biotherapeutics Inc
Pharmasum Therapeutics AS
PharmatrophiX Inc
Pharmazz Inc
PharmCADD Co Ltd
Pharnext SA
Phoenix Biotechnology Inc
Phoenix Life Sciences International Ltd
Pinteon Therapeutics Inc
Plico Biotech Inc
Polaryx Therapeutics Inc
PolyCore Therapeutics LLC
Praetego Inc
Praxis Biotech LLC
Prevacus Inc
PRG S&Tech Inc
Priavoid GmbH
Prilenia Therapeutics Development Ltd
Proclara Biosciences Inc
Progenra Inc
ProMIS Neurosciences Inc
Protekt Therapeutics Ltd
Prothena Corp Plc
Protheragen Inc
Prous Institute for Biomedical Research SA
Provaidya LLC
Provention Bio Inc
Psy Therapeutics Inc
PurMinds NeuroPharma Inc
Qingdao Primedicine Pharmaceutical Technology Co Ltd
Quimatryx SL
RAGE Biotech Pty Ltd
Reata Pharmaceuticals Inc
Regenacy Pharmaceuticals LLC
Regenera Pharma Ltd
reMYND NV
ReNeuron Group Plc
Resilio Therapeutics LLC
ResQ Biotech
Retrotope Inc
Revalesio Corp
Reven Holdings Inc
Reviva Pharmaceuticals Inc
Revivo Therapeutics Inc
Riserx LLC
Rodos BioTarget GmbH
Rznomics Inc
Sage Therapeutics Inc
Saillant Therapeutics BV
Samjin Pharm Co Ltd
Samus Therapeutics Inc
SanBio Co Ltd
Sanofi
Scientus Pharma Inc
Seelos Therapeutics, Inc.
Selonterra Inc
Sentinel Oncology Ltd
Serometrix LLC
Shanghai Angecon Biotechnology Co Ltd
Shanghai Green Valley Pharmaceutical Co Ltd
Shanghai Rixin Biological Co Ltd
Shanghai SIMR Biotech Co Ltd
Shape Therapeutics Inc
Shaperon Inc
Shenzhen Salubris Pharmaceuticals Co Ltd
Simcere Pharmaceutical Group Ltd
SinoMab Bioscience Ltd
Siragen Pharmaceuticals Inc
Sironax Ltd
Smart Biomolecules Inc
SOLA Biosciences LLC
Sosei Group Corp
SparkBioPharma Inc
Spherium Biomed SL
Spinogenix Inc
Starwise Therapeutics LLC
Stellate Therapeutics Inc
Stream Biomedical Inc
Sun Pharma Advanced Research Company Ltd
Sunovion Pharmaceuticals Inc
Suntec Medical (Taiwan) Inc
Suven Life Sciences Ltd
Synapss Therapeutics Inc
SynapTEX LLC
Synaptogenix Inc
T3D Therapeutics Inc
Taho Pharmaceuticals Ltd
TaiMed Biologics Inc
Takeda Pharmaceutical Co Ltd
Talem Therapeutics Inc
TauC3 Biologics Ltd
TauRx Therapeutics Ltd
Techfields Pharma Co Ltd
TechnoPhage SA
Teikoku Pharma USA Inc
Teitur Trophics ApS
Telocyte LLC
Tetra Therapeutics
Tetraneuron SL
Teva Pharmaceutical Industries Ltd
The Greater Cannabis Company Inc
The National Institute for Biotechnology in the Negev Ltd
Thera Neuropharma Inc
Therini Bio Inc
Tiaki Therapeutics Inc
Time Therapeutics Inc
Tiziana Life Sciences Plc
Tonix Pharmaceuticals Holding Corp
Tranquis Therapeutics Inc
Transposon Therapeutics Inc
Treeway BV
Treventis Corp
Triplet Therapeutics Inc
TrueBinding Inc
UCB SA
Uni-Bio Science Group Ltd
UniQure NV
Unity Biotechnology Inc
USA Elixiria Biotech Inc
Vaccinex Inc
Vandria SA
Vanqua Bio Inc
Vanworld Pharmaceutical (Rugao) Company Ltd
Varinel Inc
Vaxxinity Inc
VectorY Therapeutics Inc
Ventus Therapeutics Inc
VFP Therapies
Videns Incorp Ltd
Vigil Neuroscience Inc
Virogenics Inc
Virpax Pharmaceuticals Inc
Vitro Diagnostics Inc
Vitruvian Biomedical Inc
Vivoryon Therapeutics NV
Vivreon Biosciences LLC
Voyager Therapeutics Inc
VTBIO Co Ltd
Vybion Inc
Vyripharm Biopharmaceuticals
Whan In Pharm Co Ltd
Wren Therapeutics Ltd
Xigen SA
Xonovo Inc
Yasham P2D Lifesciences Pvt Ltd
Yuhan Corp
Yuma Therapeutics Corp
Yumanity Therapeutics Inc
Zensun (Shanghai) Sci & Tech Co Ltd
Zhejiang Hisun Pharmaceutical Co Ltd
Zhejiang Huahai Pharmaceutical Co Ltd
Zhittya Genesis Medicine Inc
ZZ Biotech LLC

Table of Contents

Table of Contents

List of Tables

List of Figures

Introduction

Global Markets Direct Report Coverage

Alzheimer’s Disease – Overview

Alzheimer’s Disease – Therapeutics Development

Pipeline Overview

Pipeline by Companies

Pipeline by Universities/Institutes

Products under Development by Companies

Products under Development by Universities/Institutes

Alzheimer’s Disease – Therapeutics Assessment

Assessment by Target

Assessment by Mechanism of Action

Assessment by Route of Administration

Assessment by Molecule Type

Alzheimer’s Disease – Companies Involved in Therapeutics Development

Alzheimer’s Disease – Drug Profiles

Alzheimer’s Disease – Dormant Projects

Alzheimer’s Disease – Discontinued Products

Alzheimer’s Disease – Product Development Milestones

Featured News & Press Releases

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables

List of Tables

Number of Products under Development for Alzheimer’s Disease, 2022

Number of Products under Development by Companies, 2022

Number of Products under Development by Companies, 2022 (Contd..1)

Number of Products under Development by Companies, 2022 (Contd..2)

Number of Products under Development by Companies, 2022 (Contd..3)

Number of Products under Development by Companies, 2022 (Contd..4)

Number of Products under Development by Companies, 2022 (Contd..5)

Number of Products under Development by Companies, 2022 (Contd..6)

Number of Products under Development by Companies, 2022 (Contd..7)

Number of Products under Development by Companies, 2022 (Contd..8)

Number of Products under Development by Companies, 2022 (Contd..9)

Number of Products under Development by Companies, 2022 (Contd..10)

Number of Products under Development by Companies, 2022 (Contd..11)

Number of Products under Development by Companies, 2022 (Contd..12)

Number of Products under Development by Companies, 2022 (Contd..13)

Number of Products under Development by Companies, 2022 (Contd..14)

Number of Products under Development by Companies, 2022 (Contd..15)

Number of Products under Development by Companies, 2022 (Contd..16)

Number of Products under Development by Companies, 2022 (Contd..17)

Number of Products under Development by Companies, 2022 (Contd..18)

Number of Products under Development by Companies, 2022 (Contd..19)

Number of Products under Development by Companies, 2022 (Contd..20)

Number of Products under Development by Companies, 2022 (Contd..21)

Number of Products under Development by Companies, 2022 (Contd..22)

Number of Products under Development by Companies, 2022 (Contd..23)

Number of Products under Development by Companies, 2022 (Contd..24)

Number of Products under Development by Companies, 2022 (Contd..25)

Number of Products under Development by Companies, 2022 (Contd..26)

Number of Products under Development by Companies, 2022 (Contd..27)

Number of Products under Development by Universities/Institutes, 2022

Number of Products under Development by Universities/Institutes, 2022 (Contd..1)

Number of Products under Development by Universities/Institutes, 2022 (Contd..2)

Number of Products under Development by Universities/Institutes, 2022 (Contd..3)

Number of Products under Development by Universities/Institutes, 2022 (Contd..4)

Number of Products under Development by Universities/Institutes, 2022 (Contd..5)

Number of Products under Development by Universities/Institutes, 2022 (Contd..6)

Products under Development by Companies, 2022

Products under Development by Companies, 2022 (Contd..1)

Products under Development by Companies, 2022 (Contd..2)

Products under Development by Companies, 2022 (Contd..3)

Products under Development by Companies, 2022 (Contd..4)

Products under Development by Companies, 2022 (Contd..5)

Products under Development by Companies, 2022 (Contd..6)

Products under Development by Companies, 2022 (Contd..7)

Products under Development by Companies, 2022 (Contd..8)

Products under Development by Companies, 2022 (Contd..9)

Products under Development by Companies, 2022 (Contd..10)

Products under Development by Companies, 2022 (Contd..11)

Products under Development by Companies, 2022 (Contd..12)

Products under Development by Companies, 2022 (Contd..13)

Products under Development by Companies, 2022 (Contd..14)

Products under Development by Companies, 2022 (Contd..15)

Products under Development by Companies, 2022 (Contd..16)

Products under Development by Companies, 2022 (Contd..17)

Products under Development by Companies, 2022 (Contd..18)

Products under Development by Companies, 2022 (Contd..19)

Products under Development by Companies, 2022 (Contd..20)

Products under Development by Companies, 2022 (Contd..21)

Products under Development by Companies, 2022 (Contd..22)

Products under Development by Companies, 2022 (Contd..23)

Products under Development by Companies, 2022 (Contd..24)

Products under Development by Companies, 2022 (Contd..25)

Products under Development by Companies, 2022 (Contd..26)

Products under Development by Companies, 2022 (Contd..27)

Products under Development by Companies, 2022 (Contd..28)

Products under Development by Companies, 2022 (Contd..29)

Products under Development by Companies, 2022 (Contd..30)

Products under Development by Companies, 2022 (Contd..31)

Products under Development by Companies, 2022 (Contd..32)

Products under Development by Companies, 2022 (Contd..33)

Products under Development by Companies, 2022 (Contd..34)

Products under Development by Companies, 2022 (Contd..35)

Products under Development by Companies, 2022 (Contd..36)

Products under Development by Companies, 2022 (Contd..37)

Products under Development by Companies, 2022 (Contd..38)

Products under Development by Companies, 2022 (Contd..39)

Products under Development by Companies, 2022 (Contd..40)

Products under Development by Companies, 2022 (Contd..41)

Products under Development by Companies, 2022 (Contd..42)

Products under Development by Companies, 2022 (Contd..43)

Products under Development by Universities/Institutes, 2022

Products under Development by Universities/Institutes, 2022 (Contd..1)

Products under Development by Universities/Institutes, 2022 (Contd..2)

Products under Development by Universities/Institutes, 2022 (Contd..3)

Products under Development by Universities/Institutes, 2022 (Contd..4)

Products under Development by Universities/Institutes, 2022 (Contd..5)

Products under Development by Universities/Institutes, 2022 (Contd..6)

Products under Development by Universities/Institutes, 2022 (Contd..7)

Products under Development by Universities/Institutes, 2022 (Contd..8)

Number of Products by Stage and Target, 2022

Number of Products by Stage and Target, 2022 (Contd..1)

Number of Products by Stage and Target, 2022 (Contd..2)

Number of Products by Stage and Target, 2022 (Contd..3)

Number of Products by Stage and Target, 2022 (Contd..4)

Number of Products by Stage and Target, 2022 (Contd..5)

Number of Products by Stage and Target, 2022 (Contd..6)

Number of Products by Stage and Target, 2022 (Contd..7)

Number of Products by Stage and Target, 2022 (Contd..8)

Number of Products by Stage and Target, 2022 (Contd..9)

Number of Products by Stage and Target, 2022 (Contd..10)

Number of Products by Stage and Target, 2022 (Contd..11)

Number of Products by Stage and Target, 2022 (Contd..12)

Number of Products by Stage and Mechanism of Action, 2022

Number of Products by Stage and Mechanism of Action, 2022 (Contd..1)

Number of Products by Stage and Mechanism of Action, 2022 (Contd..2)

Number of Products by Stage and Mechanism of Action, 2022 (Contd..3)

Number of Products by Stage and Mechanism of Action, 2022 (Contd..4)

Number of Products by Stage and Mechanism of Action, 2022 (Contd..5)

Number of Products by Stage and Mechanism of Action, 2022 (Contd..6)

Number of Products by Stage and Mechanism of Action, 2022 (Contd..7)

Number of Products by Stage and Mechanism of Action, 2022 (Contd..8)

Number of Products by Stage and Mechanism of Action, 2022 (Contd..9)

Number of Products by Stage and Mechanism of Action, 2022 (Contd..10)

Number of Products by Stage and Mechanism of Action, 2022 (Contd..11)

Number of Products by Stage and Mechanism of Action, 2022 (Contd..12)

Number of Products by Stage and Mechanism of Action, 2022 (Contd..13)

Number of Products by Stage and Route of Administration, 2022

Number of Products by Stage and Molecule Type, 2022

Alzheimer’s Disease – Pipeline by 1st Bio Therapeutics Inc, 2022

Alzheimer’s Disease – Pipeline by 2A Pharma AB, 2022

Alzheimer’s Disease – Pipeline by 4B Technologies (Suzhou) Co Ltd, 2022

Alzheimer’s Disease – Pipeline by 4P-Pharma SAS, 2022

Alzheimer’s Disease – Pipeline by AB Science SA, 2022

Alzheimer’s Disease – Pipeline by Abaxy Sprl, 2022

Alzheimer’s Disease – Pipeline by AbbVie Inc, 2022

Alzheimer’s Disease – Pipeline by Abrexa Pharmaceuticals Inc, 2022

Alzheimer’s Disease – Pipeline by Abyssinia Biologics LLC, 2022

Alzheimer’s Disease – Pipeline by AC Immune SA, 2022

Alzheimer’s Disease – Pipeline by Acadia Pharmaceuticals Inc, 2022

Alzheimer’s Disease – Pipeline by Accuitis Pharmaceuticals Inc, 2022

Alzheimer’s Disease – Pipeline by Acelot Inc, 2022

Alzheimer’s Disease – Pipeline by Actinogen Medical Ltd, 2022

Alzheimer’s Disease – Pipeline by Acumen Pharmaceuticals Inc, 2022

Alzheimer’s Disease – Pipeline by Addex Therapeutics Ltd, 2022

Alzheimer’s Disease – Pipeline by ADEL Inc, 2022

Alzheimer’s Disease – Pipeline by Adocia SAS, 2022

Alzheimer’s Disease – Pipeline by ADRx Inc, 2022

Alzheimer’s Disease – Pipeline by Aerobyx LLC, 2022

Alzheimer’s Disease – Pipeline by Aeton Therapeutics Inc, 2022

Alzheimer’s Disease – Pipeline by AevisBio Inc, 2022

Alzheimer’s Disease – Pipeline by AfaSci Inc, 2022

Alzheimer’s Disease – Pipeline by AIBIOS Co Ltd, 2022

Alzheimer’s Disease – Pipeline by Ailon Co Ltd, 2022

Alzheimer’s Disease – Pipeline by Akome Biotech Ltd, 2022

Alzheimer’s Disease – Pipeline by Alchemab Therapeutics Ltd, 2022

Alzheimer’s Disease – Pipeline by Alector Inc, 2022

Alzheimer’s Disease – Pipeline by Alfasigma SpA, 2022

Alzheimer’s Disease – Pipeline by Alkahest Inc, 2022

Alzheimer’s Disease – Pipeline by Alkermes Plc, 2022

Alzheimer’s Disease – Pipeline by Allyx Therapeutics Inc, 2022

Alzheimer’s Disease – Pipeline by Alnylam Pharmaceuticals Inc, 2022

Alzheimer’s Disease – Pipeline by Alopexx Inc, 2022

Alzheimer’s Disease – Pipeline by AlphaCognition Inc, 2022

Alzheimer’s Disease – Pipeline by Alsonex Pty Ltd, 2022

Alzheimer’s Disease – Pipeline by ALSP Inc, 2022

Alzheimer’s Disease – Pipeline by AltPep Corp, 2022

Alzheimer’s Disease – Pipeline by Alzamend Neuro Inc, 2022

Alzheimer’s Disease – Pipeline by AlzeCure Pharma AB, 2022

Alzheimer’s Disease – Pipeline by Alzheon Inc, 2022

Alzheimer’s Disease – Pipeline by Alzhyme Pty Ltd, 2022

Alzheimer’s Disease – Pipeline by Alzinova AB, 2022

Alzheimer’s Disease – Pipeline by AlzProtect SAS, 2022

Alzheimer’s Disease – Pipeline by Amyloid Solution Inc, 2022

Alzheimer’s Disease – Pipeline by Amylon LLC, 2022

Alzheimer’s Disease – Pipeline by Amylyx Pharmaceuticals Inc, 2022

Alzheimer’s Disease – Pipeline by AmyriAD Therapeutics BV, 2022

Alzheimer’s Disease – Pipeline by Anavex Life Sciences Corp, 2022

Alzheimer’s Disease – Pipeline by Anhorn Medicines Co Ltd, 2022

Alzheimer’s Disease – Pipeline by Anima Biotech Inc, 2022

Alzheimer’s Disease – Pipeline by Ankar Pharma SL, 2022

Alzheimer’s Disease – Pipeline by ANLBio Co Ltd, 2022

Alzheimer’s Disease – Pipeline by Annovis Bio Inc, 2022

Alzheimer’s Disease – Pipeline by Antoxerene Inc, 2022

Alzheimer’s Disease – Pipeline by Anven AlzDx Inc, 2022

Alzheimer’s Disease – Pipeline by Aphios Corp, 2022

Alzheimer’s Disease – Pipeline by Apollo Therapeutics LLC, 2022

Alzheimer’s Disease – Pipeline by Applied Research using OMIC Sciences SL, 2022

Alzheimer’s Disease – Pipeline by Aprinoia Therapeutics Inc, 2022

Alzheimer’s Disease – Pipeline by AptaBio Therapeutics Inc, 2022

Alzheimer’s Disease – Pipeline by Aquinnah Pharmaceuticals Inc, 2022

Alzheimer’s Disease – Pipeline by Araclon Biotech SL, 2022

Alzheimer’s Disease – Pipeline by Archer Pharmaceuticals Inc, 2022

Alzheimer’s Disease – Pipeline by AriBio, 2022

Alzheimer’s Disease – Pipeline by ArmaGen Inc, 2022

Alzheimer’s Disease – Pipeline by ARMGO Pharma Inc, 2022

Alzheimer’s Disease – Pipeline by Artery Therapeutics Inc, 2022

Alzheimer’s Disease – Pipeline by Arvinas Inc, 2022

Alzheimer’s Disease – Pipeline by Asceneuron SA, 2022

Alzheimer’s Disease – Pipeline by Asdera LLC, 2022

Alzheimer’s Disease – Pipeline by Ashvattha Therapeutics LLC, 2022

Alzheimer’s Disease – Pipeline by Asklepios BioPharmaceutical Inc, 2022

Alzheimer’s Disease – Pipeline by Astellas Pharma Inc, 2022

Alzheimer’s Disease – Pipeline by AstraZeneca Plc, 2022

Alzheimer’s Disease – Pipeline by Astrocyte Pharmaceuticals Inc, 2022

Alzheimer’s Disease – Pipeline by Astrogen Ltd, 2022

Alzheimer’s Disease – Pipeline by AstronauTx Ltd, 2022

Alzheimer’s Disease – Pipeline by Atalanta Therapeutics Inc, 2022

Alzheimer’s Disease – Pipeline by Athira Pharma Inc, 2022

Alzheimer’s Disease – Pipeline by ATP Biopharm, 2022

Alzheimer’s Disease – Pipeline by Atux Iskay Group LLC, 2022

Alzheimer’s Disease – Pipeline by Augustus BioTarget Inc, 2022

Alzheimer’s Disease – Pipeline by Auransa Inc, 2022

Alzheimer’s Disease – Pipeline by Aurin Biotech Inc, 2022

Alzheimer’s Disease – Pipeline by Autifony Therapeutics Ltd, 2022

Alzheimer’s Disease – Pipeline by Autophagy Neurotherapeutics Inc, 2022

Alzheimer’s Disease – Pipeline by Autotac Bio Inc, 2022

Alzheimer’s Disease – Pipeline by Avanti Biosciences Inc, 2022

Alzheimer’s Disease – Pipeline by Avidin Biotechnology Ltd, 2022

Alzheimer’s Disease – Pipeline by Avineuro Pharmaceuticals Inc, 2022

Alzheimer’s Disease – Pipeline by Axoltis Pharma SAS, 2022

Alzheimer’s Disease – Pipeline by Axon Neuroscience SE, 2022

Alzheimer’s Disease – Pipeline by Axxam SpA, 2022

Alzheimer’s Disease – Pipeline by AZTherapies Inc, 2022

Alzheimer’s Disease – Pipeline by Beijing Joekai Biotechnology LLC, 2022

Alzheimer’s Disease – Pipeline by Berg LLC, 2022

Alzheimer’s Disease – Pipeline by BeyondBio Inc, 2022

Alzheimer’s Disease – Pipeline by Bio-Pharm Solutions Co Ltd, 2022

Alzheimer’s Disease – Pipeline by BioArctic AB, 2022

Alzheimer’s Disease – Pipeline by Biogen Inc, 2022

Alzheimer’s Disease – Pipeline by Biohaven Pharmaceutical Holding Company Ltd, 2022

Alzheimer’s Disease – Pipeline by Biom Therapeutics LLC, 2022

Alzheimer’s Disease – Pipeline by Biorchestra Co Ltd, 2022

Alzheimer’s Disease – Pipeline by Biosplice Therapeutics Inc, 2022

Alzheimer’s Disease – Pipeline by BioVie Inc, 2022

Alzheimer’s Disease – Pipeline by BioXcel Therapeutics Inc, 2022

Alzheimer’s Disease – Pipeline by Bisichem Co Ltd, 2022

Alzheimer’s Disease – Pipeline by Boehringer Ingelheim International GmbH, 2022

Alzheimer’s Disease – Pipeline by Bolden Therapeutics Inc, 2022

Alzheimer’s Disease – Pipeline by Bolder Biotechnology Inc, 2022

Alzheimer’s Disease – Pipeline by Boryung Pharmaceutical Co Ltd, 2022

Alzheimer’s Disease – Pipeline by Brain Innovation Co Ltd, 2022

Alzheimer’s Disease – Pipeline by BrainStorm Cell Therapeutics Inc, 2022

Alzheimer’s Disease – Pipeline by Brainvectis SAS, 2022

Alzheimer’s Disease – Pipeline by Bright Minds Biosciences Inc, 2022

Alzheimer’s Disease – Pipeline by Buto Corp, 2022

Alzheimer’s Disease – Pipeline by C4 Therapeutics Inc, 2022

Alzheimer’s Disease – Pipeline by C4X Discovery Holdings Plc, 2022

Alzheimer’s Disease – Pipeline by Cantabio Pharmaceuticals Inc, 2022

Alzheimer’s Disease – Pipeline by Caren Pharmaceuticals Inc, 2022

Alzheimer’s Disease – Pipeline by Carna Biosciences Inc, 2022

Alzheimer’s Disease – Pipeline by CaSRevolution SRL, 2022

Alzheimer’s Disease – Pipeline by Cassava Sciences Inc, 2022

Alzheimer’s Disease – Pipeline by CavoGene LifeSciences, 2022

Alzheimer’s Disease – Pipeline by CellCure, 2022

Alzheimer’s Disease – Pipeline by CellTex Therapeutics Corp, 2022

Alzheimer’s Disease – Pipeline by Cenna Biosciences Inc, 2022

Alzheimer’s Disease – Pipeline by Cennerv Pharma (S) Pte Ltd, 2022

Alzheimer’s Disease – Pipeline by Center Laboratories Inc, 2022

Alzheimer’s Disease – Pipeline by CerebraMed, 2022

Alzheimer’s Disease – Pipeline by Cerecin Pte Ltd, 2022

Alzheimer’s Disease – Pipeline by Cerevance Inc, 2022

Alzheimer’s Disease – Pipeline by Cesa Alliance SA, 2022

Alzheimer’s Disease – Pipeline by CHA Biotech Co Ltd, 2022

Alzheimer’s Disease – Pipeline by Changchun Huayang High-Tech Co Ltd, 2022

Alzheimer’s Disease – Pipeline by Chaperone Therapeutics Inc, 2022

Alzheimer’s Disease – Pipeline by Chengdu Jinrui Foundation Biotechnology Co Ltd, 2022

Alzheimer’s Disease – Pipeline by Chengdu Kanghong Pharmaceuticals Group Co Ltd, 2022

Alzheimer’s Disease – Pipeline by Chimerna Therapeutics Inc, 2022

Alzheimer’s Disease – Pipeline by Chong Kun Dang Pharmaceutical Corp, 2022

Alzheimer’s Disease – Pipeline by Circadian Therapeutics, 2022

Alzheimer’s Disease – Pipeline by Circumvent Pharmaceuticals Inc, 2022

Alzheimer’s Disease – Pipeline by Clayton Biotechnologies Inc, 2022

Alzheimer’s Disease – Pipeline by Clene Inc, 2022

Alzheimer’s Disease – Pipeline by Clevexel Pharma SA, 2022

Alzheimer’s Disease – Pipeline by CMG Pharmaceutical Co Ltd, 2022

Alzheimer’s Disease – Pipeline by Cogentis Therapeutics Inc, 2022

Alzheimer’s Disease – Pipeline by Cognition Therapeutics Inc, 2022

Alzheimer’s Disease – Pipeline by Cognosci Inc, 2022

Alzheimer’s Disease – Pipeline by CohBar Inc, 2022

Alzheimer’s Disease – Pipeline by Collaborations Pharmaceuticals Inc, 2022

Alzheimer’s Disease – Pipeline by Collaborative Medicinal Development LLC, 2022

Alzheimer’s Disease – Pipeline by CoPlex Therapeutics LLC, 2022

Alzheimer’s Disease – Pipeline by Corium Inc, 2022

Alzheimer’s Disease – Pipeline by Cortexyme Inc, 2022

Alzheimer’s Disease – Pipeline by Cortice Biosciences Inc, 2022

Alzheimer’s Disease – Pipeline by Covalent Bioscience Inc, 2022

Alzheimer’s Disease – Pipeline by Coya Therapeutics Inc, 2022

Alzheimer’s Disease – Pipeline by Creative Bio-Peptides Inc, 2022

Alzheimer’s Disease – Pipeline by Crossbeta Biosciences BV, 2022

Alzheimer’s Disease – Pipeline by CuraSen Therapeutics Inc, 2022

Alzheimer’s Disease – Pipeline by Cure Network Dolby Acceleration Partners LLC, 2022

Alzheimer’s Disease – Pipeline by CuroNZ Ltd, 2022

Alzheimer’s Disease – Pipeline by Cyclerion Therapeutics Inc, 2022

Alzheimer’s Disease – Pipeline by Cyclica Inc, 2022

Alzheimer’s Disease – Pipeline by Cyclo Therapeutics Inc, 2022

Alzheimer’s Disease – Pipeline by CycloLab Cyclodextrin Research and Development Laboratory Ltd, 2022

Alzheimer’s Disease – Pipeline by Cytonus Therapeutics Inc, 2022

Alzheimer’s Disease – Pipeline by Dadang & BIO Co Ltd, 2022

Alzheimer’s Disease – Pipeline by Daewoong Pharmaceutical Co Ltd, 2022

Alzheimer’s Disease – Pipeline by DanDi Bioscience Inc, 2022

Alzheimer’s Disease – Pipeline by DanPET AB, 2022

Alzheimer’s Disease – Pipeline by DegenRx BV, 2022

Alzheimer’s Disease – Pipeline by Denali Therapeutics Inc, 2022

Alzheimer’s Disease – Pipeline by Denovo Biopharma LLC, 2022

Alzheimer’s Disease – Pipeline by Diffusion Pharmaceuticals Inc, 2022

Alzheimer’s Disease – Pipeline by Dong Wha Pharma Co Ltd, 2022

Alzheimer’s Disease – Pipeline by Dong-A ST Co Ltd, 2022

Alzheimer’s Disease – Pipeline by DongKoo Bio & Pharma Co Ltd, 2022

Alzheimer’s Disease – Pipeline by Dongkook Pharmaceutical Co Ltd, 2022

Alzheimer’s Disease – Pipeline by E-scape Bio Inc, 2022

Alzheimer’s Disease – Pipeline by Eagle Pharmaceuticals Inc, 2022

Alzheimer’s Disease – Pipeline by EastGate Pharmaceuticals Inc, 2022

Alzheimer’s Disease – Pipeline by Eikonizo Therapeutics Inc, 2022

Alzheimer’s Disease – Pipeline by EIP Pharma LLC, 2022

Alzheimer’s Disease – Pipeline by Eisai Co Ltd, 2022

Alzheimer’s Disease – Pipeline by Eleusis Ltd, 2022

Alzheimer’s Disease – Pipeline by Eli Lilly and Co, 2022

Alzheimer’s Disease – Pipeline by Elixirgen Therapeutics Inc, 2022

Alzheimer’s Disease – Pipeline by Elixiron Immunotherapeutics Inc, 2022

Alzheimer’s Disease – Pipeline by Emerald Organic Products Inc, 2022

Alzheimer’s Disease – Pipeline by EmphyCorp Inc, 2022

Alzheimer’s Disease – Pipeline by Empriver LLC, 2022

Alzheimer’s Disease – Pipeline by Endece LLC, 2022

Alzheimer’s Disease – Pipeline by Enterin Inc, 2022

Alzheimer’s Disease – Pipeline by Entrada Therapeutics Inc, 2022

Alzheimer’s Disease – Pipeline by Epigen Biosciences Inc, 2022

Alzheimer’s Disease – Pipeline by Epitracker Inc, 2022

Alzheimer’s Disease – Pipeline by Epsilon Molecular Engineering Inc, 2022

Alzheimer’s Disease – Pipeline by EuMentis Therapeutics Inc, 2022

Alzheimer’s Disease – Pipeline by Everfront Biotech Inc, 2022

Alzheimer’s Disease – Pipeline by Evero Health Ltd, 2022

Alzheimer’s Disease – Pipeline by Expesicor Inc, 2022

Alzheimer’s Disease – Pipeline by Exscientia Plc, 2022

Alzheimer’s Disease – Pipeline by F. Hoffmann-La Roche Ltd, 2022

Alzheimer’s Disease – Pipeline by Foresee Pharmaceuticals Co Ltd, 2022

Alzheimer’s Disease – Pipeline by Forest Hills Partners Hong Kong Ltd, 2022

Alzheimer’s Disease – Pipeline by Fortuna Fix Inc, 2022

Alzheimer’s Disease – Pipeline by Fox Chase Chemical Diversity Center Inc, 2022

Alzheimer’s Disease – Pipeline by FUJIFILM Toyama Chemical Co Ltd, 2022

Alzheimer’s Disease – Pipeline by G2GBIO Inc, 2022

Alzheimer’s Disease – Pipeline by GABA Therapeutics Inc, 2022

Alzheimer’s Disease – Pipeline by Gabaeron Inc, 2022

Alzheimer’s Disease – Pipeline by Gabather AB, 2022

Alzheimer’s Disease – Pipeline by Galimedix Therapeutics Ltd, 2022

Alzheimer’s Disease – Pipeline by GAOMA Therapeutics, 2022

Alzheimer’s Disease – Pipeline by GemVax & KAEL Co Ltd, 2022

Alzheimer’s Disease – Pipeline by Gene Therapy Research Institution Co Ltd, 2022

Alzheimer’s Disease – Pipeline by GeneLeap Biotech, 2022

Alzheimer’s Disease – Pipeline by Genentech USA Inc, 2022

Alzheimer’s Disease – Pipeline by Genervon Biopharmaceuticals LLC, 2022

Alzheimer’s Disease – Pipeline by GeneScience Pharmaceuticals Co Ltd, 2022

Alzheimer’s Disease – Pipeline by Genetic Intelligence Inc, 2022

Alzheimer’s Disease – Pipeline by Genuv Inc, 2022

Alzheimer’s Disease – Pipeline by Gismo Therapeutics Inc, 2022

Alzheimer’s Disease – Pipeline by GliaCure Inc, 2022

Alzheimer’s Disease – Pipeline by GliaPharm SA, 2022

Alzheimer’s Disease – Pipeline by Glycadia Inc, 2022

Alzheimer’s Disease – Pipeline by GNT Pharma Co Ltd, 2022

Alzheimer’s Disease – Pipeline by Golden Biotechnology Corp, 2022

Alzheimer’s Disease – Pipeline by Good T Cells Inc, 2022

Alzheimer’s Disease – Pipeline by GraySpace Therapeutics Inc, 2022

Alzheimer’s Disease – Pipeline by Grespo AB, 2022

Alzheimer’s Disease – Pipeline by Grifols SA, 2022

Alzheimer’s Disease – Pipeline by Guangzhou Dazhou Biomedical Technology Co Ltd, 2022

Alzheimer’s Disease – Pipeline by Guangzhou-Sheng Jian Chi Pharmaceutical Co Ltd, 2022

Alzheimer’s Disease – Pipeline by H. Lundbeck AS, 2022

Alzheimer’s Disease – Pipeline by Halia Therapeutics Inc, 2022

Alzheimer’s Disease – Pipeline by HEC Pharma Co Ltd, 2022

Alzheimer’s Disease – Pipeline by Herophilus, 2022

Alzheimer’s Disease – Pipeline by Holy Stone Healthcare Co Ltd, 2022

Alzheimer’s Disease – Pipeline by Hopstem Biotechnology LLC, 2022

Alzheimer’s Disease – Pipeline by Hoth Therapeutics Inc, 2022

Alzheimer’s Disease – Pipeline by Hyundai Pharma Co Ltd, 2022

Alzheimer’s Disease – Pipeline by ICB International Inc, 2022

Alzheimer’s Disease – Pipeline by Ildong Pharmaceutical Co Ltd, 2022

Alzheimer’s Disease – Pipeline by Imago Pharmaceuticals Inc, 2022

Alzheimer’s Disease – Pipeline by Immune System Key Ltd, 2022

Alzheimer’s Disease – Pipeline by Immuneering Corp, 2022

Alzheimer’s Disease – Pipeline by Immungenetics AG, 2022

Alzheimer’s Disease – Pipeline by ImmunoBrain Checkpoint Inc, 2022

Alzheimer’s Disease – Pipeline by ImmunoChem Therapeutics LLC, 2022

Alzheimer’s Disease – Pipeline by Immunwork Inc, 2022

Alzheimer’s Disease – Pipeline by Imnewrun Bioscience Co Ltd, 2022

Alzheimer’s Disease – Pipeline by Inmune Bio Inc, 2022

Alzheimer’s Disease – Pipeline by InnoBioscience LLC, 2022

Alzheimer’s Disease – Pipeline by Innosense LLC, 2022

Alzheimer’s Disease – Pipeline by Innovimmune Biotherapeutics Inc, 2022

Alzheimer’s Disease – Pipeline by Instituto Biomar SA, 2022

Alzheimer’s Disease – Pipeline by IntelGenx Corp, 2022

Alzheimer’s Disease – Pipeline by Interprotein Corp, 2022

Alzheimer’s Disease – Pipeline by Intra-Cellular Therapies Inc, 2022

Alzheimer’s Disease – Pipeline by IntraBio Ltd, 2022

Alzheimer’s Disease – Pipeline by INVENT Pharmaceuticals Inc, 2022

Alzheimer’s Disease – Pipeline by Invisio Ltd, 2022

Alzheimer’s Disease – Pipeline by Io Therapeutics Inc, 2022

Alzheimer’s Disease – Pipeline by Ionis Pharmaceuticals Inc, 2022

Alzheimer’s Disease – Pipeline by ISU ABXIS Co Ltd, 2022

Alzheimer’s Disease – Pipeline by Jace Biomedical Inc, 2022

Alzheimer’s Disease – Pipeline by Jiangsu Hengrui Medicine Co Ltd, 2022

Alzheimer’s Disease – Pipeline by Jiangsu Kangyuan Pharmaceutical Co Ltd, 2022

Alzheimer’s Disease – Pipeline by Jiangsu Kanion Pharmaceutical Co Ltd, 2022

Alzheimer’s Disease – Pipeline by Johnson & Johnson, 2022

Alzheimer’s Disease – Pipeline by Jupiter Neurosciences Inc, 2022

Alzheimer’s Disease – Pipeline by Kalgene Pharmaceuticals Inc, 2022

Alzheimer’s Disease – Pipeline by Karuna Therapeutics Inc, 2022

Alzheimer’s Disease – Pipeline by KeifeRx LLC, 2022

Alzheimer’s Disease – Pipeline by Keystone Bio Inc, 2022

Alzheimer’s Disease – Pipeline by Kine Sciences, 2022

Alzheimer’s Disease – Pipeline by KinoPharma Inc, 2022

Alzheimer’s Disease – Pipeline by Klogene Therapeutics Inc, 2022

Alzheimer’s Disease – Pipeline by Kogenix Therapeutics Inc, 2022

Alzheimer’s Disease – Pipeline by Korea Pharma Co Ltd, 2022

Alzheimer’s Disease – Pipeline by Kwang Dong Pharmaceutical Co Ltd, 2022

Alzheimer’s Disease – Pipeline by Kyowa Kirin Co Ltd, 2022

Alzheimer’s Disease – Pipeline by Landos Biopharma Inc, 2022

Alzheimer’s Disease – Pipeline by Lauren Sciences LLC, 2022

Alzheimer’s Disease – Pipeline by Lead Discovery Center GmbH, 2022

Alzheimer’s Disease – Pipeline by Lennham Pharmaceuticals Inc, 2022

Alzheimer’s Disease – Pipeline by LEXEO Therapeutics LLC, 2022

Alzheimer’s Disease – Pipeline by Libella Gene Therapeutics, 2022

Alzheimer’s Disease – Pipeline by Light Chain Bioscience, 2022

Alzheimer’s Disease – Pipeline by Longeveron Inc, 2022

Alzheimer’s Disease – Pipeline by LSL Neurosciences LLC, 2022

Alzheimer’s Disease – Pipeline by Luye Pharma Group Ltd, 2022

Alzheimer’s Disease – Pipeline by Lyndra Therapeutics Inc., 2022

Alzheimer’s Disease – Pipeline by Magnolia Neurosciences Corp, 2022

Alzheimer’s Disease – Pipeline by ManRos Therapeutics, 2022

Alzheimer’s Disease – Pipeline by MapLight therapeutics Inc, 2022

Alzheimer’s Disease – Pipeline by Marvel Biotechnology Inc, 2022

Alzheimer’s Disease – Pipeline by MaxiVAX SA, 2022

Alzheimer’s Disease – Pipeline by MD Healthcare Inc, 2022

Alzheimer’s Disease – Pipeline by MDimune Inc, 2022

Alzheimer’s Disease – Pipeline by MedBiome Inc, 2022

Alzheimer’s Disease – Pipeline by Medesis Pharma SA, 2022

Alzheimer’s Disease – Pipeline by Medifron DBT Co Ltd, 2022

Alzheimer’s Disease – Pipeline by medilabo RFP Inc, 2022

Alzheimer’s Disease – Pipeline by MEDRx Co Ltd, 2022

Alzheimer’s Disease – Pipeline by MegaNano BioTech Inc, 2022

Alzheimer’s Disease – Pipeline by MEI Pharma Inc, 2022

Alzheimer’s Disease – Pipeline by Mercia Pharma Inc, 2022

Alzheimer’s Disease – Pipeline by Merck & Co Inc, 2022

Alzheimer’s Disease – Pipeline by MetiMedi Pharmaceuticals Co Ltd, 2022

Alzheimer’s Disease – Pipeline by MetrioPharm AG, 2022

Alzheimer’s Disease – Pipeline by MetVital Inc, 2022

Alzheimer’s Disease – Pipeline by MGC Pharmaceuticals Ltd, 2022

Alzheimer’s Disease – Pipeline by Mindset Pharma Inc, 2022

Alzheimer’s Disease – Pipeline by Mission Therapeutics Ltd, 2022

Alzheimer’s Disease – Pipeline by Mitoconix Bio Ltd, 2022

Alzheimer’s Disease – Pipeline by Montisera Ltd, 2022

Alzheimer’s Disease – Pipeline by MYND Life Sciences Inc, 2022

Alzheimer’s Disease – Pipeline by NAL Pharmaceuticals Ltd, 2022

Alzheimer’s Disease – Pipeline by Nanomerics Ltd, 2022

Alzheimer’s Disease – Pipeline by NatureWise Biotech & Medicals Corp, 2022

Alzheimer’s Disease – Pipeline by Neonc Technologies Inc, 2022

Alzheimer’s Disease – Pipeline by NeoNeuro SAS, 2022

Alzheimer’s Disease – Pipeline by NeoProgen Inc, 2022

Alzheimer’s Disease – Pipeline by NervGen Pharma Corp, 2022

Alzheimer’s Disease – Pipeline by NeuExcell Therapeutics Inc, 2022

Alzheimer’s Disease – Pipeline by Neuracle Genetics Inc, 2022

Alzheimer’s Disease – Pipeline by Neuracle Science Co Ltd, 2022

Alzheimer’s Disease – Pipeline by Neuraly Inc, 2022

Alzheimer’s Disease – Pipeline by Neuramedy Co Ltd, 2022

Alzheimer’s Disease – Pipeline by Neurano Bioscience, 2022

Alzheimer’s Disease – Pipeline by Neurim Pharmaceuticals Ltd, 2022

Alzheimer’s Disease – Pipeline by Neurimmune Holding AG, 2022

Alzheimer’s Disease – Pipeline by Neuro Bio Ltd, 2022

Alzheimer’s Disease – Pipeline by Neuro-Sys SAS, 2022

Alzheimer’s Disease – Pipeline by NeuroActiva Inc, 2022

Alzheimer’s Disease – Pipeline by Neurocrine Biosciences Inc, 2022

Alzheimer’s Disease – Pipeline by Neurodegeneration Therapeutics Inc, 2022

Alzheimer’s Disease – Pipeline by Neurodon LLC, 2022

Alzheimer’s Disease – Pipeline by NeuroGeneration Inc, 2022

Alzheimer’s Disease – Pipeline by NeuroGenesis Ltd, 2022

Alzheimer’s Disease – Pipeline by NeuroGenetic Pharmaceuticals Inc, 2022

Alzheimer’s Disease – Pipeline by Neurokine Therapeutics, 2022

Alzheimer’s Disease – Pipeline by NeuroLucent Inc, 2022

Alzheimer’s Disease – Pipeline by Neuromagen Pharma Ltd, 2022

Alzheimer’s Disease – Pipeline by NeuroNascent Inc, 2022

Alzheimer’s Disease – Pipeline by NeurOp Inc, 2022

Alzheimer’s Disease – Pipeline by Neuropore Therapies Inc, 2022

Alzheimer’s Disease – Pipeline by NeuroScientific Biopharmaceuticals Ltd, 2022

Alzheimer’s Disease – Pipeline by NeuroSense Therapeutics Ltd, 2022

Alzheimer’s Disease – Pipeline by NeuroSolis Inc, 2022

Alzheimer’s Disease – Pipeline by NeuroTau Inc, 2022

Alzheimer’s Disease – Pipeline by Neurotez Inc, 2022

Alzheimer’s Disease – Pipeline by NeuroTherpia Inc, 2022

Alzheimer’s Disease – Pipeline by NeuTherapeutics Inc, 2022

Alzheimer’s Disease – Pipeline by Neuvivo Inc, 2022

Alzheimer’s Disease – Pipeline by New World Laboratories Inc, 2022

Alzheimer’s Disease – Pipeline by NewAmsterdam Pharma BV, 2022

Alzheimer’s Disease – Pipeline by Nexel Co Ltd, 2022

Alzheimer’s Disease – Pipeline by Nippon Chemiphar Co Ltd, 2022

Alzheimer’s Disease – Pipeline by NKGen Biotech Inc, 2022

Alzheimer’s Disease – Pipeline by NoNO Inc, 2022

Alzheimer’s Disease – Pipeline by Novartis AG, 2022

Alzheimer’s Disease – Pipeline by NovMetaPharma Co Ltd, 2022

Alzheimer’s Disease – Pipeline by Novoron Bioscience Inc, 2022

Alzheimer’s Disease – Pipeline by Nymox Pharmaceutical Corp, 2022

Alzheimer’s Disease – Pipeline by Olatec Therapeutics LLC, 2022

Alzheimer’s Disease – Pipeline by Oleolive LLC, 2022

Alzheimer’s Disease – Pipeline by Oligomerix inc, 2022

Alzheimer’s Disease – Pipeline by OncoSynergy Inc, 2022

Alzheimer’s Disease – Pipeline by Ono Pharmaceutical Co Ltd, 2022

Alzheimer’s Disease – Pipeline by Orpheris Inc, 2022

Alzheimer’s Disease – Pipeline by Orphi Therapeutics Inc, 2022

Alzheimer’s Disease – Pipeline by Oryzon Genomics SA, 2022

Alzheimer’s Disease – Pipeline by OTR3 SAS, 2022

Alzheimer’s Disease – Pipeline by Overseas Pharmaceuticals Ltd, 2022

Alzheimer’s Disease – Pipeline by Oxstem Ltd, 2022

Alzheimer’s Disease – Pipeline by P2D Inc, 2022

Alzheimer’s Disease – Pipeline by Palisade Bio, Inc, 2022

Alzheimer’s Disease – Pipeline by Panorama Researchama Research, 2022

Alzheimer’s Disease – Pipeline by Paramag Biosciences, 2022

Alzheimer’s Disease – Pipeline by Park of Active Molecules, 2022

Alzheimer’s Disease – Pipeline by Paros Bio Inc, 2022

Alzheimer’s Disease – Pipeline by Partner Therapeutics Inc, 2022

Alzheimer’s Disease – Pipeline by Passage Bio Inc, 2022

Alzheimer’s Disease – Pipeline by Peptron Inc, 2022

Alzheimer’s Disease – Pipeline by Perha Pharmaceuticals SAS, 2022

Alzheimer’s Disease – Pipeline by Peter Biotherapeutics Inc, 2022

Alzheimer’s Disease – Pipeline by Pharmasum Therapeutics AS, 2022

Alzheimer’s Disease – Pipeline by PharmatrophiX Inc, 2022

Alzheimer’s Disease – Pipeline by Pharmazz Inc, 2022

Alzheimer’s Disease – Pipeline by PharmCADD Co Ltd, 2022

Alzheimer’s Disease – Pipeline by Pharnext SA, 2022

Alzheimer’s Disease – Pipeline by Phoenix Biotechnology Inc, 2022

Alzheimer’s Disease – Pipeline by Phoenix Life Sciences International Ltd, 2022

Alzheimer’s Disease – Pipeline by Pinteon Therapeutics Inc, 2022

Alzheimer’s Disease – Pipeline by Plico Biotech Inc, 2022

Alzheimer’s Disease – Pipeline by Polaryx Therapeutics Inc, 2022

Alzheimer’s Disease – Pipeline by PolyCore Therapeutics LLC, 2022

Alzheimer’s Disease – Pipeline by Praetego Inc, 2022

Alzheimer’s Disease – Pipeline by Praxis Biotech LLC, 2022

Alzheimer’s Disease – Pipeline by Prevacus Inc, 2022

Alzheimer’s Disease – Pipeline by PRG S&Tech Inc, 2022

Alzheimer’s Disease – Pipeline by Priavoid GmbH, 2022

Alzheimer’s Disease – Pipeline by Prilenia Therapeutics Development Ltd, 2022

Alzheimer’s Disease – Pipeline by Proclara Biosciences Inc, 2022

Alzheimer’s Disease – Pipeline by Progenra Inc, 2022

Alzheimer’s Disease – Pipeline by ProMIS Neurosciences Inc, 2022

Alzheimer’s Disease – Pipeline by Protekt Therapeutics Ltd, 2022

Alzheimer’s Disease – Pipeline by Prothena Corp Plc, 2022

Alzheimer’s Disease – Pipeline by

List of Figures

List of Figures

Number of Products under Development for Alzheimer’s Disease, 2022

Number of Products under Development by Companies, 2022

Number of Products under Development by Universities/Institutes, 2022

Number of Products by Top 10 Targets, 2022

Number of Products by Stage and Top 10 Targets, 2022

Number of Products by Top 10 Mechanism of Actions, 2022

Number of Products by Stage and Top 10 Mechanism of Actions, 2022

Number of Products by Top 10 Routes of Administration, 2022

Number of Products by Stage and Top 10 Routes of Administration, 2022

Number of Products by Top 10 Molecule Types, 2022

Number of Products by Stage and Top 10 Molecule Types, 2022

Frequently Asked Questions

The targets of the Alzheimer’s disease pipeline drugs market are Amyloid Beta A4 Protein, Microtubule Associated Protein Tau, Acetylcholinesterase, Glutamate Ionotropic Receptor NMDA Type Subunit, Apolipoprotein E, Muscarinic Acetylcholine Receptor M1, Gamma Secretase, Alpha Synuclein, Cholinesterase, and Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A.

The mechanisms of action of the Alzheimer’s disease pipeline drugs market are Amyloid Beta A4 Protein Inhibitor, Microtubule Associated Protein Tau Inhibitor, Acetylcholinesterase Inhibitor, Glutamate Ionotropic Receptor NMDA Type Subunit Antagonist, Muscarinic Acetylcholine Receptor M1 Agonist, Apolipoprotein E Inhibitor, Alpha Synuclein Inhibitor, Cholinesterase Inhibitor, Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Inhibitor, and Muscarinic Acetylcholine Receptor M4 Agonist.

The routesThe mechanisms of action of the Alzheimer’s disease pipeline drugs market are Amyloid Beta A4 Protein Inhibitor, Microtubule Associated Protein Tau Inhibitor, Acetylcholinesterase Inhibitor, Glutamate Ionotropic Receptor NMDA Type Subunit Antagonist, Muscarinic Acetylcholine Receptor M1 Agonist, Apolipoprotein E Inhibitor, Alpha Synuclein Inhibitor, Cholinesterase Inhibitor, Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Inhibitor, and Muscarinic Acetylcholine Receptor M4 Agonist. of administration in the Alzheimer’s disease pipeline drugs market are oral, intravenous, subcutaneous, nasal, parenteral, transdermal, intrathecal, inhalational, intramuscular, and topical.

The molecule types in the Alzheimer’s disease pipeline drugs market are small molecule, monoclonal antibody, synthetic peptide, gene therapy, peptide, cell therapy, biologic, antibody, recombinant protein, and antisense oligonucleotide.

$2,500

Can be used by individual purchaser only

$7,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Get in touch to find out about our multi-purchase discounts

reportstore@globaldata.com
Tel +44 (0) 20 7947 2960

Every customer’s requirement is unique. We understand that and can customize the report basis your exact research requirements pertaining to market insights, innovation insights, strategy and planning, and competitive intelligence. You can also avail the option of purchasing stand-alone sections of the report or request for a country specific report.

GDPR + CCPA Compliant

Personal and transaction information are kept safe from unauthorised use.

Recently Viewed Reports

Testimonial

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods
Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.